Filing Details
- Accession Number:
- 0001209191-18-062518
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-13 18:36:39
- Reporting Period:
- 2018-12-11
- Accepted Time:
- 2018-12-13 18:36:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1609727 | Synthorx Inc. | THOR | Pharmaceutical Preparations (2834) | 464709185 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760431 | Tighe Reardon | C/O Synthorx, Inc. 11099 N. Torrey Pines Road, Suite 190 La Jolla CA 92037 | Acting Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-11 | 1,136,631 | $0.00 | 1,136,631 | No | 4 | C | Indirect | By Avalon X SPV I, L.P. |
| Common Stock | Acquisiton | 2018-12-11 | 545,455 | $11.00 | 1,682,086 | No | 4 | P | Indirect | By Avalon X SPV I, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By Avalon X SPV I, L.P. |
| No | 4 | P | Indirect | By Avalon X SPV I, L.P. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series C Preferred Stock | Disposition | 2018-12-11 | 1,821,156 | $0.00 | 1,136,631 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 43,688 | Direct |
Footnotes
- Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1.60224-to-1 basis. The shares have no expiration date.
- The Reporting Person is Chief Financial Officer and Partner of Avalon X SPV GP LLC, general partner of Avalon X SPV I, L.P., and shares voting and investment power with respect to the shares held by Avalon X SPV I, L.P. The Reporting Person disclaims beneficial ownership of the shares held by Avalon X SPV I, L.P., except to the extent of his actual pecuniary interest therein if any.
- The shares were purchased at the Issuer's initial public offering.
Billionaire Hedge Funds
